Carlton Hofferkamp & Jenks Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$456K Hold
392
0.15% 94
2026
Q1
$340K Hold
392
0.11% 109
2025
Q4
$421K Hold
392
0.14% 98
2025
Q3
$324K Hold
392
0.11% 110
2025
Q2
$298K Sell
392
-10
-2% -$7.77K 0.11% 110
2025
Q1
$295K Hold
402
0.12% 110
2024
Q4
$339K Hold
402
0.13% 108
2024
Q3
$324K Hold
402
0.12% 110
2024
Q2
$318K Hold
402
0.12% 110
2024
Q1
$291K Buy
402
+5
+1% +$3.56K 0.12% 107
2023
Q4
$252K Hold
397
0.11% 117
2023
Q3
$233K Sell
397
-258
-39% -$133K 0.11% 116
2023
Q2
$294K Sell
655
-180
-22% -$75.5K 0.13% 109
2023
Q1
$364K Sell
835
-150
-15% -$50.6K 0.17% 100
2022
Q4
$337K Sell
985
-100
-9% -$35.5K 0.15% 103
2022
Q3
$370K Hold
1,085
0.17% 101
2022
Q2
$359K Sell
1,085
-30
-3% -$9.01K 0.16% 102
2022
Q1
$348K Hold
1,115
0.14% 105
2021
Q4
$267K Hold
1,115
0.11% 119
2021
Q3
$290K Sell
1,115
-120
-10% -$29.6K 0.12% 124
2021
Q2
$287K Buy
1,235
+50
+4% +$10K 0.12% 117
2021
Q1
$216K Buy
+1,185
New +$232K 0.1% 123

Other funds holding LLY

Carlton Hofferkamp & Jenks Wealth Management's LLY Position: Q2 2026 in Review

Carlton Hofferkamp & Jenks Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 392 shares worth $456K. The position accounts for 0.15% of the portfolio, ranked #94.

Carlton Hofferkamp & Jenks Wealth Management first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Carlton Hofferkamp & Jenks Wealth Management held 392 shares of Eli Lilly worth $456K as of Q2 2026.
  • Carlton Hofferkamp & Jenks Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.15% of Carlton Hofferkamp & Jenks Wealth Management's portfolio in Q2 2026, its #94 holding.
  • Carlton Hofferkamp & Jenks Wealth Management first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Carlton Hofferkamp & Jenks Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.